Literature DB >> 27867029

Genotypic diversity of porcine circovirus type 2 (PCV2) and genotype shift to PCV2d in Korean pig population.

Taeyong Kwon1, Dong-Uk Lee1, Sung J Yoo1, Sang H Je1, Jeong Y Shin1, Young S Lyoo2.   

Abstract

Porcine circovirus type 2 (PCV2) is a causative agent of PCV2-associated disease (PCVAD), which leads to enormous economic losses in the swine industry worldwide. A high nucleotide substitution rate allows for the continuous evolution of PCV2 and the emergence of novel PCV2 strains. However, the distribution of emerging PCV2 genotypes and the co-existence of multiple genotypes in Korea have not been elucidated. The objective of this study was to determine the genetic diversity of PCV2 in Korean pig herds between 2009 and 2016. The overall prevalence of PCV2, from various samples originating from commercial pigs, was 53.8% (325/604). Two cases of a genotype shift to PCV2d at the farm level showed that the genotype shift started before 2012. In addition, genotype-specific PCR, on pen-based oral fluid samples for nationwide PCV2 surveillance in 2016, indicated that the infection pattern of PCV2 genotypes at the farm level was as follows; none (6/69), PCV2a (6/69), PCV2b (2/69), PCV2d (33/69), PCV2a/b (2/69), PCV2a/d (4/69), PCV2b/d (11/69), and PCV2a/b/d (2/69), respectively. This suggests that the genotype shift to PCV2d occurred on a nationwide scale and that the co-existence of different genotypes is common in Korean pig herds. In addition, seven sites on the capsid protein of Korean PCV2 were identified as being under positive selection pressure, all of which are related to the epitope region and neutralization activity. These data provide evidence of increased genetic diversity and shifts among Korean PCV2 isolates.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genotype shift; PCV2d; Porcine circovirus type 2; Selection pressure

Mesh:

Year:  2016        PMID: 27867029     DOI: 10.1016/j.virusres.2016.11.015

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  29 in total

1.  A comparative efficacy test of 1 versus 2 doses of CIRCOQ PCV2 subunit vaccine against naturally occurring PCV2-type d in piglets with high maternally derived antibodies (MDAs) on a Vietnamese swine farm.

Authors:  Duy Tien Do; Khanh Doan Vinh Tran; Anh Tuyet Quach; David Lee; Frank Cj Chang; Carol Py Wu; Toan Nguyen Tat; Chanhee Chae
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

2.  Molecular genotypic analysis of porcine circovirus type 2 reveals the predominance of PCV2d in Vietnam (2018-2020) and the association between PCV2h, the recombinant forms, and Vietnamese vaccines.

Authors:  Huong Thi Thanh Doan; Roan Thi Do; Pham Thi Phuong Thao; Xuyen Thi Kim Le; Khue Thi Nguyen; Nguyen Thi Thu Hien; Luu Minh Duc; Linh Thi Khanh Pham; Thanh Hoa Le
Journal:  Arch Virol       Date:  2022-07-06       Impact factor: 2.685

3.  Comparative growth performance of 3 types of combination vaccines containing porcine circovirus 2 and Mycoplasma hyopneumoniae under field conditions.

Authors:  Siyeon Yang; Joo Young Lee; Taehwan Oh; Kee Hwan Park; Hyejean Cho; Jeongmin Suh; Kyung-Duk Min; Hee Jin Ham; Chanhee Chae
Journal:  Can J Vet Res       Date:  2022-04       Impact factor: 0.897

4.  Multiplex polymerase chain reaction for the detection and differentiation of 4 porcine circovirus 2 genotypes (PCV-2a, -2b, -2d, and -2e) in clinical samples.

Authors:  Kee Hwan Park; Hyejean Cho; Taehwan Oh; Siyeon Yang; Chanhee Chae
Journal:  Can J Vet Res       Date:  2022-04       Impact factor: 0.897

5.  Comparative study of the virulence of 3 major Korean porcine circovirus type 2 genotypes (a, b, and d).

Authors:  Hyejean Cho; Ikjae Kang; Taehwan Oh; Siyeon Yang; Kee Hwan Park; Kyung-Duk Min; Hee Jin Ham; Chanhee Chae
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

6.  A field efficacy trial of a trivalent vaccine containing porcine circovirus type 2a and 2b, and Mycoplasma hyopneumoniae in three herds.

Authors:  Hyungmin Um; Siyeon Yang; Taehwan Oh; Hyejean Cho; Kee Hwan Park; Jeongmin Suh; Chanhee Chae
Journal:  Vet Med Sci       Date:  2021-10-22

Review 7.  Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology.

Authors:  Anbu K Karuppannan; Tanja Opriessnig
Journal:  Viruses       Date:  2017-05-06       Impact factor: 5.048

Review 8.  Global Status of Porcine circovirus Type 2 and Its Associated Diseases in Sub-Saharan Africa.

Authors:  Kayode O Afolabi; Benson C Iweriebor; Anthony I Okoh; Larry C Obi
Journal:  Adv Virol       Date:  2017-03-12

9.  Comparative Evaluation of Growth Performance between Bivalent and Trivalent Vaccines Containing Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae in a Herd with Subclinical PCV2d Infection and Enzootic Pneumonia.

Authors:  Hyungmin Um; Siyeon Yang; Taehwan Oh; Keehwan Park; Hyejean Cho; Jeongmin Suh; Kyung-Duk Min; Chanhee Chae
Journal:  Vaccines (Basel)       Date:  2021-05-03

Review 10.  Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure.

Authors:  Sung J Yoo; Taeyong Kwon; Young S Lyoo
Journal:  Clin Exp Vaccine Res       Date:  2018-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.